WurmFM. Production of recombinant protein therapeutics in cultivated mammalian cells. Nat Biotechnol, 2004; 22,11:1393–1398.
2.
WestfallPJ, PiteraDJ, LenihanJRet al.Production of amorphadiene in yeast, and its conversion to dihydroartemisinic acid, precursor to the antimalarial agent artemisinin. Proc Natl Acad Sci, 2012; 109,3:E111–118.
3.
MannMS, Lutke-EverslohT. Thiolase engineering for enhanced butanol production in Clostridium acetobutylicum. Biotechnol Bioeng, 2013; 110,3:887–897.
4.
GulevichAY, SkorokhodovaAY, SukhozhenkoAVet al.Metabolic engineering of Escherichia coli for 1-butanol biosynthesis through the inverted aerobic fatty acid beta-oxidation pathway. Biotechnol Lett, 2012; 34,3:463–469.
5.
LarkumAW, RossIL, KruseO, HankamerB. Selection, breeding and engineering of microalgae for bioenergy and biofuel production. Trends Biotechnol, 2012; 30,4:198–205.
6.
YimH, HaselbeckR, NiuWet al.Metabolic engineering of Escherichia coli for direct production of 1,4-butanediol. Nat Chem Biol, 2011; 7,7:445–452.
7.
PaddonCJ, WestfallPJ, PiteraDJet al.High-level semi-synthetic production of the potent antimalarial artemisinin. Nature, 2013; 496,7446:528–532.
8.
Change The World: Sapphire Energy's Green Crude Farm, Illustrated. www.sapphireenergy.com/news-article/1212040-change-the-world-sapphire-energy-s-green. 2013July.
9.
ThieleI, PalssonBO. A protocol for generating a high-quality genome-scale metabolic reconstruction. Nat Protoc, 2010; 5,1:93–121.
10.
PriceND, ReedJL, PalssonBO. Genome-scale models of microbial cells: Evaluating the consequences of constraints. Nat Rev Microbiol, 2004; 2,11:886–897.
11.
MilneCB, KimPJ, EddyJA, PriceND. Accomplishments in genome-scale in silico modeling for industrial and medical biotechnology. Biotechnol J, 2009; 4,12:1653–1670.
12.
SchellenbergerJ, QueR, FlemingRMet al.Quantitative prediction of cellular metabolism with constraint-based models: The COBRA Toolbox v2.0. Nat Protoc, 2011; 6,9:1290–1307.
